New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareGlutathione vs Dulaglutide

Glutathione vs Dulaglutide

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & LongevityImmune Support
Glutathione
GLP-1 / Weight Loss Agonists
Dulaglutide
Summary
Glutathione is the body's master endogenous antioxidant tripeptide, composed of glutamate, cysteine, and glycine. It neutralizes reactive oxygen species, supports detoxification in the liver, recycles other antioxidants (vitamins C and E), and plays a central role in immune function, DNA repair, and cellular redox balance.
Dulaglutide (brand name Trulicity) is a once-weekly GLP-1 receptor agonist approved by the FDA for type 2 diabetes management and cardiovascular risk reduction. It consists of two GLP-1 analog chains fused to a modified IgG4 Fc fragment, extending its half-life to approximately 5 days. While primarily a diabetes medication, it produces meaningful weight loss and has established cardiovascular outcomes data from the REWIND trial.
Half-Life
Minutes to hours depending on route; IV half-life approximately 10-30 minutes
~5 days
Admin Route
Oral (liposomal preferred), Sublingual, Intravenous, Nebulized/inhaled, Topical
SubQ
Research
Typical Dose
250-1000 mg per day
0.75 mg → 1.5 mg
Frequency
Once or twice daily
Once weekly
Key Benefits
  • Primary endogenous antioxidant and free radical scavenger
  • Supports hepatic detoxification of xenobiotics and heavy metals
  • Recycles vitamins C and E to maintain antioxidant network
  • Modulates immune function and T-cell activity
  • Skin brightening via inhibition of tyrosinase (IV/topical routes)
  • Neuroprotective in oxidative stress-related conditions
  • Mitochondrial protection and energy metabolism support
  • FDA-approved for type 2 diabetes
  • Once-weekly subcutaneous dosing via auto-injector pen
  • Reduces HbA1c by approximately 1.1–1.6%
  • Modest weight loss of 1.5–3 kg at approved doses
  • Demonstrated cardiovascular risk reduction (REWIND trial)
  • Established long-term safety profile
  • Renal protective effects in CKD
Side Effects
  • Oral bioavailability is limited (largely hydrolyzed in gut); liposomal or sublingual forms preferred
  • IV administration: rare allergic reactions, vein irritation
  • High-dose supplementation may cause zinc depletion over time
  • Inhaled glutathione may trigger bronchoconstriction in asthmatics
  • Nausea (most common, typically transient)
  • Diarrhea
  • Vomiting
  • Decreased appetite
  • +3 more
Stacks With